Simple predictors of survival in head and neck squamous cell carcinoma.
OBJECTIVE
To develop a simple prognostic survival rule from easily obtained characteristics of patients undergoing potentially curative resection of head and neck squamous cell carcinoma using classification and regression trees.


METHODS
Inception cohort.


METHODS
Tertiary care center.


METHODS
Consecutive patients undergoing resection lasting at least 2 hours, from July 1993 through June 1997.


METHODS
Survival, age, TNM tumor stage, functional class, systolic and diastolic blood pressure, body mass index, and serum albumin concentration were evaluated as predictors.


RESULTS
Four hundred six patients were followed up for 5 to 1446 days (median, 391 days), during which time 172 deaths occurred. Median survival was 687 days. Patients with TNM stage I, II, or III squamous cell carcinoma had a mean survival of 1068 days. Patients with TNM stage IV or recurrent disease were further stratified. Those with a serum albumin concentration less than 3.85 g/dL had a median survival of 404 days (95% confidence interval, 286-532 days), and those with an serum albumin concentration of 3.85 g/dL or above had a median survival of 625 days (95% confidence interval, 536-1032 days). A similar survival was found using age younger than 66.5 years as a predictor instead of serum albumin concentration less than 3.85 g/dL.


CONCLUSIONS
At our institution, patients with stage I, II, or III squamous cell carcinoma had a mean survival of approximately 3 years. Those with stage IV or recurrent squamous cell carcinoma could be stratified by either serum albumin concentration or by age into 2 groups with a median survival of 1 or 2 years.
Medow
Mitchell A
MA
Division of General Internal Medicine, Department of Otolaryngology, The Arthur G. James Cancer Hospital, Columbus, OH, USA. medow.1@osu.edu
Weed
Harrison G
HG
Schuller
David E
DE
D000328:Adult; D017677:Age Distribution; D000368:Aged; D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D015331:Cohort Studies; D016001:Confidence Intervals; D005260:Female; D006258:Head and Neck Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection / Q000379:methods / Q000401:mortality; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012044:Regression Analysis; D017678:Sex Distribution; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors